Celsius Holdings, Inc. (NASDAQ:CELH – Get Free Report) has received a consensus rating of “Moderate Buy” from the eighteen research firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and twelve have assigned a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $47.78.
Several analysts have issued reports on CELH shares. TD Cowen cut Celsius from a “buy” rating to a “hold” rating and dropped their target price for the company from $40.00 to $29.00 in a research report on Wednesday, January 22nd. Morgan Stanley reaffirmed an “equal weight” rating and set a $42.00 target price on shares of Celsius in a research report on Thursday, December 26th. Jefferies Financial Group dropped their target price on Celsius from $44.00 to $40.00 and set a “buy” rating on the stock in a research report on Thursday, December 19th. UBS Group dropped their target price on Celsius from $45.00 to $39.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. Finally, Deutsche Bank Aktiengesellschaft began coverage on Celsius in a research report on Thursday, December 12th. They issued a “hold” rating and a $32.00 price objective for the company.
Read Our Latest Report on Celsius
Celsius Stock Up 7.7 %
Celsius (NASDAQ:CELH – Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.03. The business had revenue of $332.20 million for the quarter, compared to analysts’ expectations of $326.07 million. Celsius had a return on equity of 51.89% and a net margin of 10.70%. Equities analysts anticipate that Celsius will post 0.89 earnings per share for the current year.
Insiders Place Their Bets
In other Celsius news, major shareholder William H. Milmoe sold 65,000 shares of Celsius stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $31.15, for a total transaction of $2,024,750.00. Following the completion of the sale, the insider now owns 261,245 shares of the company’s stock, valued at approximately $8,137,781.75. The trade was a 19.92 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.20% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Celsius
Institutional investors have recently modified their holdings of the stock. HM Payson & Co. raised its stake in shares of Celsius by 122.2% during the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company’s stock valued at $26,000 after buying an additional 550 shares during the last quarter. S.A. Mason LLC raised its stake in shares of Celsius by 100.0% during the 4th quarter. S.A. Mason LLC now owns 1,400 shares of the company’s stock valued at $37,000 after buying an additional 700 shares during the last quarter. Activest Wealth Management purchased a new position in shares of Celsius during the 3rd quarter valued at about $39,000. GAMMA Investing LLC raised its stake in shares of Celsius by 185.7% during the 4th quarter. GAMMA Investing LLC now owns 1,714 shares of the company’s stock valued at $45,000 after buying an additional 1,114 shares during the last quarter. Finally, Blue Trust Inc. raised its stake in shares of Celsius by 32.8% during the 4th quarter. Blue Trust Inc. now owns 1,786 shares of the company’s stock valued at $47,000 after buying an additional 441 shares during the last quarter. Hedge funds and other institutional investors own 60.95% of the company’s stock.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Read More
- Five stocks we like better than Celsius
- What Investors Need to Know About Upcoming IPOs
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Stock Dividend Cuts Happen Are You Ready?
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- There Are Different Types of Stock To Invest In
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.